Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Future antiglaucoma drug candidates added to the pipeline at Alcon

Aug. 24, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Sugen reaches milestone in collaborative agreement with Allergan

Aug. 10, 1998

First SELEX compound from NeXstar heads for clinical trials in ARMD

July 27, 1998

Troponin I inhibits retinal angiogenesis in animal studies

July 27, 1998

Herpes simplex virus vaccine reduces HSV-1 corneal disease

July 24, 1998

BioLon receives FDA approval

July 23, 1998

FDA grants fast track status to Miravant's Purlytin

July 10, 1998

Allergan signs collaborative agreement with Santen for brimonidine

July 10, 1998

Clinical update on Advanced Corneal Systems' Vitrase

July 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...